Is Grace Therapeutics, Inc. (GRCE) a Buy, Sell, or Hold?
NASDAQ : GRCE
Grace Therapeutics, Inc. — Competitors
$2.33 USD
-$0.02 (-0.85%)
- Volume
- 127.04K
- Average Volume
- 484.53K
- Market Capitalization
- $37.92M
- P/E Ratio
- -4.19
- Dividend Yield
- 0.00%
- Price Target
- $4.00
- Year High
- $5.18
- Year Low
- $1.79
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $8.10
GRCE vs. The Competition
| Properties | GRCE | ABVC | ATNM | CALC |
|---|---|---|---|---|
| Market Cap | $37.92M | $16.66M | $26.98M | $12M |
| Shares Outstanding | $16.27M | $14.49M | $31.37M | $15.8M |
| P/E Ratio | -4.19 | -10.01 | -1.15 | -0.57 |
| EPS | -0.55 | -0.37 | -0.75 | -1.3 |
| Day Low | 2.29 | 1.145 | 0.86 | 0.68 |
| Day High | 2.34 | 1.17 | 0.8723 | 0.7599 |
| Year Low | 1.79 | 0.88 | 0.86 | 0.461 |
| Year High | 5.18 | 3.4 | 1.86 | 7.2 |
| Average Price 50 | 2.3494 | 1.3496 | 1.05176 | 0.80588 |
| Average Price 200 | 3.22015 | 1.82199 | 1.23852 | 2.10741 |
| Volume | 127.04K | 84341 | 113.15K | 268.14K |
| Average Volume | - | - | - | - |